Clinicopathologic characteristics and survival of patients with clinical Stage I squamous cell carcinomas of the thoracic esophagus treated with three-field lymph node …

…, H Daiko, M Fukaya, S Yajima… - European journal of …, 2001 - academic.oup.com
Objective: Clinicopathologic characteristics and survival rates of patients with clinical Stage
I tumors treated with three-field lymph node dissection have not been well investigated. This …

NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers

Y Oshima, H Shimada, S Yajima, T Nanami… - Journal of …, 2016 - Springer
Background Although serum NY-ESO-1 antibodies (s-NY-ESO-1-Abs) have been reported
in patients with esophageal carcinoma, this assay system has not been used to study a large …

Laparoscopic hepatectomy for hepatocellular carcinoma in cirrhotic patients

H Kaneko, M Tsuchiya, Y Otsuka, S Yajima… - Journal of hepato-biliary …, 2009 - Springer
Introduction We have used laparoscopic hepatectomy as a surgical treatment for HCC in
patients with cirrhosis. We describe the indications, evaluate invasiveness and analyze the …

[HTML][HTML] Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 …

H Kato, K Miyakawa, N Ohtake, Y Yamaoka, S Yajima… - Vaccine, 2022 - Elsevier
To evaluate vaccine-induced humoral and cell-mediated immunity at 6 months after completion
of two doses of BNT162b2 vaccination, immunoglobulin G against SARS-CoV-2 spike …

Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent …

…, N Ohtake, H Go, Y Yamaoka, S Yajima… - Journal of Infection and …, 2022 - Elsevier
Background Levels of 50% neutralizing titer (NT50) reflect the a vaccine-induced humoral
immunity after the vaccination against the severe acute respiratory syndrome coronavirus-2 (…

Beta-1 blocker improves survival of septic rats through preservation of gut barrier function

K Mori, H Morisaki, S Yajima, T Suzuki, A Ishikawa… - Intensive care …, 2011 - Springer
Objective Since recent study demonstrated beneficial effects of β-adrenergic blocker in sepsis,
we tested the hypothesis that infusion of selective β1-blocker, esmolol, improves outcome …

Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer

T Suzuki, H Shimada, T Nanami, Y Oshima, S Yajima… - Surgery Today, 2016 - Springer
Purpose Hyperfibrinogenemia is associated with poor prognosis in various cancers; however,
its clinical relevance in gastric cancer has not been well analyzed. We conducted this …

Panel of autoantibodies against multiple tumor‐associated antigens for detecting gastric cancer

…, M Tagawa, K Matsushita, Y Satoshi… - Cancer …, 2017 - Wiley Online Library
Gastric cancer is the second leading cause of cancer death in the world, and effective
diagnosis is extremely important for good outcome. We assessed the diagnostic potential of an …

Expression profiling of fecal colonocytes for RNA-based screening of colorectal cancer

S Yajima, M Ishii, H Matsushita… - International …, 2007 - spandidos-publications.com
The early detection of colorectal cancer originating from any part of the colorectum is desirable
because this cancer can be cured surgically if diagnosed early. We searched for marker …

[HTML][HTML] Association of serum anti-PCSK9 antibody levels with favorable postoperative prognosis in esophageal cancer

M Ito, T Hiwasa, Y Oshima, S Yajima, T Suzuki… - Frontiers in …, 2021 - frontiersin.org
Background Esophageal cancer often appears as postoperative metastasis or recurrence
after radical surgery. Although we had previously reported that serum programmed cell death …